Neurones (NRO) AI Stock Analysis

• Market Cap: €920.84M
• Dividend Yield: 3.59%
• Average Volume (3M): 6.80K
• Price to Earnings (P/E): 18.2
• Beta (1Y): 0.34
• Revenue Growth: 5.78%
• EPS Growth: -1.04%
• Country: FR
• Employees: 7,099
• Sector: General
• Sector Strength: N/A
• Industry: Information Technology Services
• EPS (TTM): 2.14
• Shares Outstanding: 24,328,716
• 10 Day Avg. Volume: 4,639
• 30 Day Avg. Volume: 6,801
• PEG Ratio: -14.55
• Price to Book (P/B): 3.11
• Price to Sales (P/S): 1.45
• P/FCF Ratio: 17.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 2.33
• Revenue Forecast (FY): €904.35M

• Rating: 76 Outperform
• Price Target: €44.00 ▲(16.25% Upside)
• Action: Upgraded
• Date: 08/06/26

Positive Factors

Conservative balance sheet / low leverage

Sustained very low leverage and rising equity provide financial flexibility for reinvestment, absorbing cyclical revenue dips and funding managed-service contracts. This reduces solvency risk and supports strategic spending or bolt-on M&A without stressing cash flow over the medium term.

Negative Factors

Gross-margin volatility

Large swings in gross margin suggest exposed cost structure or shifting revenue mix between high‑value consulting and low-margin operations. This undermines margin predictability, complicates long-term margin guidance, and increases earnings risk when utilization or pricing pressure tightens.

Neurones Business Overview & Revenue Model

Company Description

Neurones S.A., an information technology (IT) services provider founded in 1984 and headquartered in Nanterre, France, operates with a global reach. The company delivers a broad spectrum of services encompassing infrastructure, application develop...

Read more

Neurones S.A., an information technology (IT) services provider founded in 1984 and headquartered in Nanterre, France, operates with a global reach. The company delivers a broad spectrum of services encompassing infrastructure, application develop...

How the Company Makes Money

Neurones makes money primarily by selling IT services to business customers under two main delivery modes: (1) project-based work and (2) recurring/managed services. Project-based revenue typically comes from consulting and delivery engagements su...

Read more

Neurones makes money primarily by selling IT services to business customers under two main delivery modes: (1) project-based work and (2) recurring/managed services. Project-based revenue typically comes from consulting and delivery engagements su...

Neurones Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	857.20M	810.40M	741.17M	665.38M	579.88M
Gross Profit	90.04M	388.76M	346.76M	81.64M	69.73M
EBITDA	90.32M	85.92M	96.63M	88.72M	76.23M
Net Income	52.07M	52.50M	49.41M	44.24M	37.71M
Balance Sheet
Total Assets	749.03M	725.69M	674.25M	616.22M	567.82M
Cash, Cash Equivalents and Short-Term Investments	340.78M	326.49M	297.76M	272.06M	265.17M
Total Debt	36.96M	42.02M	43.98M	35.57M	35.32M
Total Liabilities	284.16M	289.52M	266.34M	240.63M	214.90M
Stockholders Equity	399.98M	378.10M	354.39M	330.58M	311.56M
Cash Flow
Free Cash Flow	70.33M	72.34M	54.09M	44.33M	58.10M
Operating Cash Flow	80.77M	84.38M	72.08M	54.94M	64.68M
Investing Cash Flow	-21.16M	-19.69M	-21.57M	-12.26M	-10.62M
Financing Cash Flow	-45.11M	-34.48M	-27.06M	-36.08M	-55.42M

Neurones Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 37.85
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:NRO, the sentiment is Positive. The current price of 37.85 is above the 20-day moving average (MA) of 36.89, above the 50-day MA of 36.04, and above the 200-day MA of 37.14, indicating a bullish trend. The MACD of 0.85 indicates Negative momentum. The RSI at 55.92 is Neutral, neither overbought nor oversold. The STOCH value of 63.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:NRO.

Neurones Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SOP	77 Outperform	€3.64B	11.89	14.63%	3.42%	1.62%	12.95%
NRO	76 Outperform	€920.84M	18.22	13.51%	3.67%	5.78%	-1.04%
WAVE	74 Outperform	€850.61M	10.39	12.19%	1.18%	1.13%	8.32%
ATE	70 Outperform	€2.65B	24.79	4.84%	2.40%	-1.07%	-42.78%
CAP	70 Outperform	€18.52B	13.25	10.95%	3.78%	6.23%	-11.48%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
ATO	42 Neutral	€626.07M	-0.51	319.82%	―	-14.39%	-173.10%

Neurones Corporate Events